The challenge of personal genomics in Germany

Nature Biotechnology

Volumn 31, Issue 1, 2013, Pages 16-17

  Vayena, Effy ^a   Prainsack, Barbara ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DECISION MAKING; GENETIC ANALYSIS; GENOMICS; GERMANY; HEALTH SERVICE; LAW; LETTER; PRIORITY JOURNAL;

GENOME, HUMAN; GERMANY; HUMANS; INDIVIDUALIZED MEDICINE;

EID: 84872194863     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.2469     Document Type: Letter

References (11)

1. Wright, C.F. & Gregory-Jones, S. Genet. Med. 12, 594
2. Wright, C. & MacArthur, D.G. Direct to consumer genetic testing. in Molecular Genetics and Personalized Medicine. Molecular and Translational Medicine (eds.
3. Best, D.H. & Swensen, J.J.) 215 (Springer, 2012
4. European Science Foundation (ESF). Personalised Medicine for the European Citizen. A Forward Look Report (ESF, 2012
5. Topol, E. The Creative Destruction of Medicine: How the Digital Revolution Will Create Better Health Care (Basic Books, 2012
6. Kaphingst, K.A. et al. Genet. Med. 14, 681-687
7. Bloss, C. et al. N. Engl. J. Med. 364, 524-534
8. Anonymous. Lancet 379, 386 (2012
9. Borry, P. et al. Eur. J. Hum. Genet. 20, 715-721
10. European Academies Science Advisory Council & the Federation of European Academies of Medicine.
11. Direct-to-Consumer Genetic Testing for Health-Related Purposes in the European Union: The View from EASAC and FEAM (EASAC policy report 18) (EASAC, 2012